The time has come to target connective tissue growth factor in diabetic complications

Diabetologia. 2004 Jun;47(6):965-8. doi: 10.1007/s00125-004-1423-6. Epub 2004 May 28.

Authors

S M Twigg¹, M E Cooper

Affiliation

¹ Discipline of Medicine, University of Sydney, New South Wales 2006, Australia. stwigg@med.usyd.edu.au

PMID: 15168021
DOI: 10.1007/s00125-004-1423-6

No abstract available

MeSH terms

Animals
Australia
Connective Tissue Growth Factor
Diabetes Complications / chemically induced*
Diabetes Complications / physiopathology
Diabetes Complications / prevention & control*
Diabetic Nephropathies / chemically induced
Diabetic Nephropathies / metabolism
Humans
Immediate-Early Proteins / adverse effects*
Immediate-Early Proteins / physiology
Intercellular Signaling Peptides and Proteins / adverse effects*
Intercellular Signaling Peptides and Proteins / physiology
Methods
Models, Biological

Substances

CCN2 protein, human
Immediate-Early Proteins
Intercellular Signaling Peptides and Proteins
Connective Tissue Growth Factor